With an eye toward expanding patient access and growing market share while using existing clinical resources, Genesis Health System has selected Bright.md’s SmartExam to power this new telehealth offering. Patients in the bi-state region of the Quad Cities metropolitan area and the surrounding communities of Iowa and Illinois will have access to another convenient, affordable way to get care for hundreds of low-acuity conditions.
“Demand for virtual care options was growing even before people around the country were asked to stay home due to COVID-19,” said Dr. Kurt Andersen, Senior Vice President, Physician Operations/Chief Medical Officer President of Genesis Health System. “With Bright.md’s innovative telehealth delivery platform and our umbrella of convenient care services, we’re well-positioned to address the situation at hand—for both coronavirus-infected patients and those with other conditions—and be prepared to serve the needs of our patients in a post-COVID-19 landscape.”
With the Rise of AI, What IP Disputes in Healthcare Are Likely to Emerge?
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
The SmartExam platform works like a virtual assistant to the provider, by guiding patients through a dynamic, online medical interview and sending the collected information and the patient’s medical history to a reviewing provider. The clinical decision support and automation built into SmartExam allows a provider to deliver care for conditions ranging from flu and allergies to bladder infections and lower back pain.
Science 37 raised $40 million in Series D funding round led by contract research organization Pharmaceutical Product Development (PPD). Existing investors also participated such as dRx Capital (a Qualcomm and Novartis joint investments company), Redmile Group, Lux Capital, Glynn Capital, and GV (formerly Google Ventures). Click here to read more.
A Personalized Approach to Medication Nonadherence
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.
Altitude Lab, a new incubator focused on early stage life science and healthcare companies located at University of Utah Research Park, has announced the first startups in its space including: Known Med, 3Helix, and NexEos Bio. The initiative is part of an economic development push by biotech business Recursion and the University of Utah. Click here to read more.
Carrot Fertility, a startup managing fertility benefits for employers, has raised $24 million in new capital. The business will use the new funding to advance its global expansion and expand its telehealth services. Click here to read more.
Tickets are available for INVEST Digital Health from September 21-25, INVEST Population Health November 16-18 and INVEST Precision Medicine December 9-11. Click these links to check for agenda updates. For ticket information, click here.
Picture: akindo, Getty Images
